Understanding Parkinson’s Disease Beyond Dopamine
Parkinson’s disease is a neurological problem characterised as a brain illness due to diminished dopamine production. As you can see, dopamine is still not a beneficial neurotransmitter; it helps control movement, co-ordination, muscle tone and day-to-day function. In fact, Parkinsons disease is more than just a loss of dopamine.
From a wider perspective of neurodegenerative care in general, Parkinson’s may also include neuroinflammation, mitochondrial stress, oxidative stress, increased accumulation of abnormal protein and disruption to the lines of communication between nerve cells.
This explains why patients present with diverse symptoms: tremor, slowness of movement (bradykinesia), rigidity, difficulty walking and balancing (postural instability), softer voice (hypophonia), swallowing difficulties, problems addressed by external links are not part of this summary, sleep disturbance, fatigue, constipation or mood swings or memory-related issues.
Parkinsons Disease Neuroinflammation: Why Does it Matter?
Neuroinflammation is defined as inflammatory activity or immune-mediated activation within the nervous system. In Parkinson’s disease, it could increase the stress load on vulnerable neurons.
While it is not a major player in the cause of Parkinson’s disease, neuroinflammation may play an important role in chronic nerve cell stress and resilience to cellular damage, leading to progression of the condition over time.
This is why Parkinsons care should not be limited to dopamine or drugs only. A comprehensive approach should also include the microenvironment at the level of the nervous system, regulation of inflammation, cellular energy, and functional rehabilitation.
Mitochondrial Stress and Oxidative Stress
High levels of energy are required for nerve cells to function, communicate and move. Mitochondria are the powerhouses of cells and play a vital role in neurodegenerative disorders.
Cellular resistance may be impaired by mitochondrial dependency of cell death and by oxidative stress in diseases like Parkinson’s. When nerves do a poorer job of handling stress, neurons may communicate poorly and functioning gradually deteriorates. That is exactly why supportive care might target cellular stress response, energy balance, and the health of the nervous system environment.
Figure 1: UC-MSCs as Supportive Cellular Signaling in Comprehensive Parkinson’s Disease Care
UC-MSCs as Supportive Cellular Signalling
Umbilical cord-derived mesenchymal stem cells (UC-MSCs) are a potential source of biological signals for regenerative medicine. Such signals may comprise growth factors, cytokines, extracellular vesicles (EVs), and other bioactive molecules.
It must not be considered a miracle cure, such as generating dopaminergic neurons for Parkinson’s disease. UC-MSC effects may be better explained as supportive cellular signalling.
Their proposed function could be to assist cellular signalling, modulate immunity, balance inflammation, reduce oxidative stress and help maintain the tissue milieu surrounding nerve cells in a chosen subset of patients.
What Families Should Understand
Realistic expectations are key for the families of patients with Parkinson’s disease. UC-MSCs are not the answer and should never replace a neurologist.
A detailed Parkinson support plan can include:
Regular follow-up with a neurologist
Parkinson’s medication as prescribed
Standalone or in combination with physiotherapy for gait, balance, posture and strength
In-home occupational therapy for daily activities and safety
Speech and swallow support as needed
Home environment modification and fall prevention
Nutrition, sleep and emotional support, training in care-giving.
The goal is not just biological targeting, but rather to allow the patient to function safely and more comfortably in daily life.
Rehabilitation in Parkinson’s Disease
Rehabilitation is particularly valuable because Parkinson’s affects movement, independence, and safety. Physiotherapy covers balance, gait training, posture correction, muscle strengthening, flexibility, and fall prevention.
Occupational therapy can aid patients in their daily living activities, helping them learn how to dress, get out of a chair, walk safely around the home, use utensils while eating, and maintain an organised routine, among other tasks that may help prevent falls.
If a patient presents with a soft voice, unclear speech, coughing with meals, or swallowing difficulty, these may also be red flags for the need for swallowing support and feeding therapy.
Any physiological-based therapy is more efficacious when used in conjunction with supervised rehabilitation and continuous neurological treatment.
Conclusion: This is not a standard treatment, but rather supportive care
Introduction to UC-MSCs and moderate Parkinson’s disease: we should note that they are significant in supporting neuroinflammation balance, mitochondrial stress, oxidative stress regulation, and cellular communication processes. But UC-MSCs are not magic, do not guarantee any regeneration of dopamine-producing cells, and are no substitute for the best in neurological care.
The most responsible strategy is an integrated care plan that combines neurologist provision, drug prescription, on-market physiotherapy and occupational therapy, speech and language pathology, and swallowing support, with additional risk monitoring. It aims to promote movement, safety, comfort and quality of life over time.
Get In Touch
Address
3/6, The Primary 101, Soi Lad Phrao 101, Lad Phrao Road, Khlong Chan, Bang Kapi District, Bangkok 10240 Thailand
vegastemcell@gmail.com
Tel & WhatsApp
+66 (0) 65 528 2599
Others Pathway
Facebook: vegastemcell
Instagram: vegastemcell
www.vegastemcell.com
TikTok: @vegastemcell
YouTube: @vegastemcell